| Cat. No. |
Product Name |
Information |
| PC-45870 |
CX4945
CK2α inhibitor
|
CX-4945 (Silmitasertib, CX4945) is a potent, selective, orally bioavailable, ATP-competitive inhibitor of protein kinase Casein Kinase 2 (CK2) with Ki of 0.38 nM, CK2α IC50 of 1 nM. |
| PC-42523 |
D4476
CK1 inhibitor
|
D4476 (Casein Kinase I Inhibitor, D 4476, D-4476) is a potent, selective ATP-competitive inhibitor of CK1 with IC50 of 0.3 uM in vitro. |
| PC-42026 |
SR-3029
CK1δ/ε inhibitor
|
SR-3029 is a potent, highly selective, ATP-competitive and brain penetrating Casein Kinase 1δ/ε (CK1δ/ε) inhibitor with IC50 of 44/260 nM, respectively. |
| PC-42058 |
TA-01
CK1δ/ε inhibitor, p38α inhibitor
|
TA-01 is a potent inhibitor of Casein Kinase CK1ε, CK1δ and p38α with IC50 of 6.4, 6.8 and 6.7 nM, respectively. |
| PC-28443 |
DFMNTU
CK2 inhibitor
|
DFMNTU is a small molecule casein kinase 2 (CK2) inhibitor with IC50 of 22 uM for CK2α, potently inhibits Yellow fever virus (YFV)-induced cytopathic effects with EC50 of 4.3 ug/mL(neutral red uptake) and 2.4 ug/mL (visual CPE assessment). |
| PC-26451 |
LaCKL inhibitor B-AZ
LaCKL inhibitor, Clock modulator
|
LaCKL inhibitor B-AZ is a small-molecule L. aequinoctialis clock modulator and inhibitor of L. aequinoctialis Casein kinase 1 like (LaCKL) binds to the ATP-binding pocket of LaCKL, manipulates photoperiodic flowering. |
| PC-26375 |
CK2 inhibitor TF
CK2 inhibitor
|
CK2 inhibitor TF is a potent, selective competitive inhibitor of protein kinase CK2 (Casein kinase 2) with Ki of 15 nM and IC50 of 29 nM. |
| PC-26318 |
VRK1/CK1-IN-1
VRK1/CK1 inhibitor
|
VRK1/CK1-IN-1 is a potent, dual inhibitor of Vaccinia-related kinase 1 (VRK1) and the δ and ε isoforms of casein kinase 1 (CK1) with Ki of 37.9 nM for VRK1, and IC50 of 17 nM and 15 nM for CK1δ and CK1ε, mimics the cellular outcomes of VRK1 depletion. |
| PC-26111 |
GW869516X
CK2 inhibitor
|
GW869516X is a highly potent casein kinase 2 (CK2) inhibitor with IC50 of 85 nM and 34 nM for CSNK2A1 (CK2α) and CSNK2A2 (CK2α') in recombinant kinase assays, and IC50 of 446 and 319 nM in NanoBRET assays. |
| PC-26004 |
BMS-159
CK2 inhibitor
|
BMS-159 is the orally bioavailabile phosphate prodrug of BMS-135, which is a potent, ATP-competitive inhibitor of Casein kinase 2 (CK2), exhibits subnanomolar potency against both CK2α and CK2α′ isoforms with IC50 of 0.8 nM and 0.3 nM, respectively. |
| PC-26003 |
BMS-135
CK2 inhibitor
|
BMS-135 is a potent, ATP-competitive inhibitor of Casein kinase 2 (CK2), exhibits subnanomolar potency against both CK2α and CK2α′ isoforms with IC50 of 0.8 nM and 0.3 nM, respectively. |
| PC-25908 |
IGS-2.7
CK1δ inhibitor
|
IGS-2.7 is a potent, selective and brain permeable CK1delta (CK-1δ, CK1δ) inhibitor with IC50 of 23 nM, >35-fold selective over CK1ε (IC50=840 nM). |
